KPTI
NASDAQ · Biotechnology
Karyopharm Therapeutics Inc
$0.05
-0.01 (-8.65%)
Open$0.05
Previous Close$0.06
Day High$0.06
Day Low$0.04
52W High$10.99
52W Low—
Volume—
Avg Volume41.37M
Market Cap907.3K
P/E Ratio—
EPS$-12.84
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+89,408.2% upside
Current
$0.05
$0.05
Target
$49.14
$49.14
$31.72
$49.14 avg
$61.64
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 220.75M | 226.17M | 24.30M |
| Net Income | -296,266,835 | -273,196,876 | -4,467,152 |
| Profit Margin | -134.2% | -127.5% | -18.4% |
| EBITDA | -230,884,766 | -224,734,147 | -5,147,496 |
| Free Cash Flow | — | — | -3,231,735 |
| Rev Growth | -2.4% | -2.4% | +18.6% |
| Debt/Equity | 3.78 | 3.78 | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |